$CBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST BIOSCIENCES, INC.. Get notifications about new insider transactions in CATALYST BIOSCIENCES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 07 2021 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Option Exercise | M | 4.63 | 5,000 | 23,150 | 259,783 | |
Apr 07 2021 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Buy | M | 4.63 | 5,000 | 23,150 | 17,174 | 12.2 K to 17.2 K (+41.07 %) |
Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,215 | 0 | 18,102 | 16.9 K to 18.1 K (+7.19 %) |
Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Grant | A | 0.00 | 2,331 | 0 | 13,364 | 11 K to 13.4 K (+21.13 %) |
Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 4,761 | 0 | 13,192 | 8.4 K to 13.2 K (+56.47 %) |
Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 2,480 | 0 | 15,997 | 13.5 K to 16 K (+18.35 %) |
Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,926 | 0 | 22,807 | 19.9 K to 22.8 K (+14.72 %) |
Feb 22 2021 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Buy | P | 4.81 | 582 | 2,799 | 12,174 | 11.6 K to 12.2 K (+5.02 %) |
Feb 22 2021 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | P | 4.81 | 1,670 | 8,033 | 23,390 | 21.7 K to 23.4 K (+7.69 %) |
Feb 10 2021 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Option Exercise | A | 5.89 | 140,000 | 824,600 | 140,000 | |
Feb 10 2021 | CBIO | CATALYST BIOSCIENC ... | Musil Clinton | Chief Financial Off ... | Option Exercise | A | 5.89 | 54,000 | 318,060 | 54,000 | |
Feb 10 2021 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | A | 5.89 | 25,000 | 147,250 | 25,000 | |
Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 940 | 0 | 16,887 | 15.9 K to 16.9 K (+5.89 %) |
Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Grant | A | 0.00 | 1,782 | 0 | 11,033 | 9.3 K to 11 K (+19.26 %) |
Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,417 | 0 | 8,431 | 5 K to 8.4 K (+68.15 %) |
Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 1,881 | 0 | 13,517 | 11.6 K to 13.5 K (+16.17 %) |
Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,129 | 0 | 19,881 | 17.8 K to 19.9 K (+11.99 %) |
Oct 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 5,014 | 0 | 5,014 | 0 to 5 K |
Oct 02 2020 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 2,761 | 0 | 11,636 | 8.9 K to 11.6 K (+31.11 %) |
Oct 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 3,125 | 0 | 17,752 | 14.6 K to 17.8 K (+21.36 %) |
Aug 12 2020 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Buy | P | 4.81 | 582 | 2,799 | 11,592 | 11 K to 11.6 K (+5.29 %) |
Aug 12 2020 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | P | 4.81 | 1,768 | 8,504 | 4,268 | 2.5 K to 4.3 K (+70.72 %) |
Jul 02 2020 | CBIO | CATALYST BIOSCIENC ... | Musil Clinton | Chief Financial Off ... | Option Exercise | A | 5.88 | 140,000 | 823,200 | 140,000 | |
Jul 02 2020 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,011 | 0 | 14,567 | 13.6 K to 14.6 K (+7.46 %) |
Jul 02 2020 | CBIO | CATALYST BIOSCIENC ... | TETLOW SHARON | Director | Grant | A | 0.00 | 1,703 | 0 | 3,635 | 1.9 K to 3.6 K (+88.15 %) |
Jul 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,673 | 0 | 24,215 | 20.5 K to 24.2 K (+17.88 %) |
Jul 02 2020 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 2,076 | 0 | 8,875 | 6.8 K to 8.9 K (+30.53 %) |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | TETLOW SHARON | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | TETLOW SHARON | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | TETLOW SHARON | Director | Grant | A | 0.00 | 1,932 | 0 | 1,932 | 0 to 1.9 K |
Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | TETLOW SHARON | Director | Grant | A | 0.00 | 1,932 | 0 | 1,932 | 0 to 1.9 K |
Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Grant | A | 0.00 | 1,932 | 0 | 4,932 | 3 K to 4.9 K (+64.40 %) |
Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Grant | A | 0.00 | 1,932 | 0 | 4,932 | 3 K to 4.9 K (+64.40 %) |
Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 4,934 | 0 | 20,542 | 15.6 K to 20.5 K (+31.61 %) |
Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,860 | 0 | 12,498 | 9.6 K to 12.5 K (+29.67 %) |
Mar 17 2020 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | P | 4.05 | 2,500 | 10,132 | 2,500 | 0 to 2.5 K |
Mar 13 2020 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Buy | P | 3.91 | 4,000 | 15,647 | 11,010 | 7 K to 11 K (+57.06 %) |
Mar 13 2020 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 3.98 | 2,500 | 9,950 | 3,716 | 1.2 K to 3.7 K (+205.59 %) |
Mar 13 2020 | CBIO | CATALYST BIOSCIENC ... | Cai Veronica | Controller | Buy | P | 4.11 | 2,000 | 8,220 | 7,353 | 5.4 K to 7.4 K (+37.36 %) |
Mar 04 2020 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Buy | P | 5.78 | 2,000 | 11,560 | 10,839 | 8.8 K to 10.8 K (+22.63 %) |
Feb 27 2020 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Buy | P | 6.23 | 3,000 | 18,692 | 3,000 | 0 to 3 K |
Feb 25 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Sell | S | 6.10 | 69,401 | 423,506 | 0 | 69.4 K to 0 (-100.00 %) |
Feb 12 2020 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Grant | A | 6.23 | 430 | 2,679 | 7,010 | 6.6 K to 7 K (+6.53 %) |
Feb 12 2020 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Grant | A | 6.23 | 1,358 | 8,460 | 1,358 | 0 to 1.4 K |
Feb 12 2020 | CBIO | CATALYST BIOSCIENC ... | Cai Veronica | Controller | Grant | A | 6.23 | 1,678 | 10,454 | 5,353 | 3.7 K to 5.4 K (+45.66 %) |
Jan 27 2020 | CBIO | CATALYST BIOSCIENC ... | Cai Veronica | Controller | Option Exercise | A | 6.85 | 12,000 | 82,200 | 12,000 | |
Jan 27 2020 | CBIO | CATALYST BIOSCIENC ... | Cai Veronica | Controller | Option Exercise | A | 6.22 | 3,000 | 18,660 | 3,000 | |
Jan 27 2020 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | A | 6.85 | 45,000 | 308,250 | 45,000 | |
Jan 27 2020 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Option Exercise | A | 6.85 | 115,000 | 787,750 | 115,000 | |
Jan 17 2020 | CBIO | CATALYST BIOSCIENC ... | TETLOW SHARON | Director | Option Exercise | A | 7.29 | 10,000 | 72,900 | 10,000 | |
Jan 17 2020 | CBIO | CATALYST BIOSCIENC ... | Ling Geoffrey M.D. | Director | Option Exercise | A | 7.29 | 10,000 | 72,900 | 10,000 | |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,743 | 0 | 8,839 | 7.1 K to 8.8 K (+24.56 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,166 | 0 | 15,608 | 12.4 K to 15.6 K (+25.45 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 1,073 | 0 | 5,126 | 4.1 K to 5.1 K (+26.47 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 1,835 | 0 | 9,638 | 7.8 K to 9.6 K (+23.52 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,743 | 0 | 8,839 | 7.1 K to 8.8 K (+24.56 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 3,166 | 0 | 15,608 | 12.4 K to 15.6 K (+25.45 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 1,073 | 0 | 5,126 | 4.1 K to 5.1 K (+26.47 %) |
Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 1,835 | 0 | 9,638 | 7.8 K to 9.6 K (+23.52 %) |
Oct 02 2019 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 2,418 | 0 | 7,096 | 4.7 K to 7.1 K (+51.69 %) |
Oct 02 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 4,391 | 0 | 12,442 | 8.1 K to 12.4 K (+54.54 %) |
Oct 02 2019 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 1,489 | 0 | 4,053 | 2.6 K to 4.1 K (+58.07 %) |
Oct 02 2019 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,545 | 0 | 7,803 | 5.3 K to 7.8 K (+48.40 %) |
Aug 12 2019 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Grant | A | 6.51 | 1,180 | 7,682 | 3,744 | 2.6 K to 3.7 K (+46.02 %) |
Aug 12 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Grant | A | 6.51 | 413 | 2,689 | 6,580 | 6.2 K to 6.6 K (+6.70 %) |
Jul 02 2019 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,642 | 0 | 4,678 | 3 K to 4.7 K (+54.08 %) |
Jul 02 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,905 | 0 | 8,051 | 5.1 K to 8.1 K (+56.45 %) |
Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
May 28 2019 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 8.03 | 1,000 | 8,030 | 1,216 | 216 to 1.2 K (+462.96 %) |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Option Exercise | M | 4.63 | 4,400 | 20,372 | 264,783 | |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Gift | G | 0.00 | 4,400 | 0 | 8,456 | 4.1 K to 8.5 K (+108.48 %) |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Gift | G | 0.00 | 4,400 | 0 | 6,167 | 10.6 K to 6.2 K (-41.64 %) |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Buy | M | 4.63 | 4,400 | 20,372 | 10,567 | 6.2 K to 10.6 K (+71.35 %) |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | M | 4.63 | 4,400 | 20,372 | 81,218 | |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Gift | G | 0.00 | 16,094 | 0 | 16,094 | 32.2 K to 16.1 K (-50.00 %) |
May 22 2019 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | M | 4.63 | 4,400 | 20,372 | 16,094 | 11.7 K to 16.1 K (+37.63 %) |
Apr 02 2019 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,364 | 0 | 3,036 | 1.7 K to 3 K (+81.58 %) |
Apr 02 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,414 | 0 | 5,146 | 2.7 K to 5.1 K (+88.36 %) |
Feb 13 2019 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Grant | A | 7.04 | 1,002 | 7,054 | 3,731 | 2.7 K to 3.7 K (+36.72 %) |
Feb 13 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Grant | A | 7.04 | 350 | 2,464 | 6,167 | 5.8 K to 6.2 K (+6.02 %) |
Feb 13 2019 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Grant | A | 7.04 | 2,485 | 17,494 | 11,867 | 9.4 K to 11.9 K (+26.49 %) |
Jan 28 2019 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President and CEO | Option Exercise | A | 7.97 | 80,000 | 637,600 | 80,000 | |
Jan 28 2019 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Option Exercise | A | 7.97 | 38,000 | 302,860 | 38,000 | |
Jan 28 2019 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | A | 7.97 | 35,000 | 278,950 | 35,000 | |
Jan 03 2019 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Grant | A | 0.00 | 1,544 | 0 | 1,672 | 128 to 1.7 K (+1,206.25 %) |
Jan 03 2019 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 2,732 | 0 | 2,732 | 0 to 2.7 K |
Jan 03 2019 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Grant | A | 0.00 | 811 | 0 | 811 | 0 to 811 |
Jan 03 2019 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 1,703 | 0 | 1,944 | 241 to 1.9 K (+706.64 %) |
Nov 27 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | M | 4.63 | 149 | 690 | 87,118 | |
Nov 27 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | M | 4.63 | 149 | 690 | 7,709 | 7.6 K to 7.7 K (+1.97 %) |
Nov 16 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | M | 4.63 | 173 | 801 | 87,267 | |
Nov 16 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Sell | S | 11.00 | 173 | 1,903 | 7,560 | 7.7 K to 7.6 K (-2.24 %) |
Nov 16 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | M | 4.63 | 173 | 801 | 7,733 | 7.6 K to 7.7 K (+2.29 %) |
Sep 06 2018 | CBIO | CATALYST BIOSCIENC ... | HILL STEPHEN A | Director | Sell | D | 10.07 | 190 | 1,913 | 1,190 | 1.4 K to 1.2 K (-13.77 %) |
Aug 01 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Option Exercise | A | 9.68 | 75,000 | 726,000 | 75,000 | |
Aug 01 2018 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Option Exercise | A | 9.68 | 25,000 | 242,000 | 25,000 | |
Aug 01 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | A | 9.68 | 35,000 | 338,800 | 35,000 | |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | HILL STEPHEN A | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
May 04 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | M | 4.63 | 7,560 | 35,003 | 87,440 | |
May 04 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Buy | M | 4.63 | 7,560 | 35,003 | 7,560 | 0 to 7.6 K |
Apr 11 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Gift | G | 0.00 | 88 | 0 | 4,144 | 4.1 K to 4.1 K (+2.17 %) |
Apr 11 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Gift | G | 0.00 | 88 | 0 | 0 | 88 to 0 (-100.00 %) |
Apr 11 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Gift | G | 0.00 | 88 | 0 | 4,144 | 4.1 K to 4.1 K (+2.17 %) |
Apr 11 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Gift | G | 0.00 | 88 | 0 | 0 | 88 to 0 (-100.00 %) |
Apr 06 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Option Exercise | M | 4.63 | 88 | 407 | 274,912 | |
Apr 06 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President & CEO | Buy | M | 4.63 | 88 | 407 | 88 | 0 to 88 |
Mar 28 2018 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Option Exercise | M | 4.63 | 59 | 273 | 74,941 | |
Mar 28 2018 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Buy | M | 4.63 | 59 | 273 | 59 | 0 to 59 |
Mar 08 2018 | CBIO | CATALYST BIOSCIENC ... | Flynn James E | 10% Owner | Sell | S | 29.03 | 8,123 | 235,811 | 1,113,222 | 1.1 M to 1.1 M (-0.72 %) |
Mar 08 2018 | CBIO | CATALYST BIOSCIENC ... | Flynn James E | 10% Owner | Sell | S | 30.00 | 1,194 | 35,820 | 1,121,345 | 1.1 M to 1.1 M (-0.11 %) |
Mar 08 2018 | CBIO | CATALYST BIOSCIENC ... | Flynn James E | 10% Owner | Sell | S | 30.00 | 10,000 | 300,000 | 1,122,539 | 1.1 M to 1.1 M (-0.88 %) |
Mar 08 2018 | CBIO | CATALYST BIOSCIENC ... | Flynn James E | 10% Owner | Sell | S | 31.18 | 39,300 | 1,225,374 | 1,132,539 | 1.2 M to 1.1 M (-3.35 %) |
Mar 08 2018 | CBIO | CATALYST BIOSCIENC ... | Flynn James E | 10% Owner | Sell | S | 29.94 | 13,161 | 394,040 | 1,171,839 | 1.2 M to 1.2 M (-1.11 %) |
Feb 22 2018 | CBIO | CATALYST BIOSCIENC ... | HILL STEPHEN A | Director | Option Exercise | J | 137.85 | 21,600 | 2,977,560 | 0 | |
Feb 22 2018 | CBIO | CATALYST BIOSCIENC ... | HILL STEPHEN A | Director | Option Exercise | J | 137.85 | 21,600 | 2,977,560 | 0 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | A | 4.40 | 10,000 | 44,000 | 10,000 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | D | 4.40 | 10,000 | 44,000 | 0 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | A | 28.20 | 500 | 14,100 | 500 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | D | 28.20 | 500 | 14,100 | 0 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | A | 66.00 | 450 | 29,700 | 450 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | D | 66.00 | 450 | 29,700 | 0 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | A | 66.00 | 550 | 36,300 | 550 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | D | 66.00 | 550 | 36,300 | 0 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | A | 157.20 | 197 | 30,968 | 197 | |
Jan 18 2018 | CBIO | CATALYST BIOSCIENC ... | SELICK HAROLD E | Director | Option Exercise | D | 157.20 | 197 | 30,968 | 0 | |
Jan 16 2018 | CBIO | CATALYST BIOSCIENC ... | USMAN NASSIM | President and CEO | Option Exercise | A | 15.13 | 95,000 | 1,437,350 | 95,000 | |
Jan 16 2018 | CBIO | CATALYST BIOSCIENC ... | Payne Fletcher | Chief Financial Off ... | Option Exercise | A | 15.13 | 26,000 | 393,380 | 26,000 | |
Jan 16 2018 | CBIO | CATALYST BIOSCIENC ... | Levy Howard | Chief Medical Offic ... | Option Exercise | A | 15.13 | 33,000 | 499,290 | 33,000 | |
Jan 02 2018 | CBIO | CATALYST BIOSCIENC ... | Williams Eddie | Director | Option Exercise | A | 14.37 | 10,000 | 143,700 | 10,000 | |
Oct 26 2017 | CBIO | CATALYST BIOSCIENC ... | Hunt Andrea | Director | Option Exercise | A | 4.72 | 10,000 | 47,200 | 10,000 | |
Jul 17 2017 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 4.40 | 10,000 | 44,000 | 10,000 |